Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption
Antioxidants · 12.12.2025 · 14 (12) · 1494
DOI: 10.3390/antiox14121494 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 12.12.2025. Verfasst von Martha Lucinda Contreras-Zentella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Colonia Copilco, Dele…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Metabolic dysfunction–associated fatty liver disease (MASLD) is associated with severe forms of liver injury, including fibrosis and cirrhosis. The main risk factors for MASLD—obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, and insulin resistance (IR)—contribute to metabolic disturbances that initiate hepatic steatosis. Metabolic and alcohol-related liver disease (MetALD) describes patients with MASLD who also present alcohol-associated hepatic injury. Chronic oxidative and inflammatory stress promotes the progression of steatosis in both conditions. T2DM and chronic alcohol consumption are independent lifestyle-related risk factors for cirrhosis within the spectrum of metabolic dysfunction–related liver disease (MASLD and MetALD). The coexistence of both conditions may exacerbate hepatic pathological alterations. IR, which is frequently observed in patients with cirrhosis, can lead to the development of a condition known as hepatogenic diabetes (HD). HD is characterized by hyperinsulinemia, IR, and β-cell dysfunction occurring during the onset of cirrhosis and is associated with hepatic inflammation even in the absence of traditional metabolic risk factors such as obesity or a prior history of T2DM. In this context, alcohol intake enhances lipolysis in peripheral tissues, promotes hepatic steatosis, and aggravates metabolic dysfunction, ultimately contributing to excessive mitochondrial production of reactive oxygen species (ROS). Therefore, the present review examines the role of oxidative stress—both alcohol-related and non-alcohol–related—in the pathogenesis of HD, with particular emphasis on ethanol metabolism, oxidative stress, and their interactions in conditions such as T2DM and MetALD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Colonia Copilco, Delegación Coyoacán, Ciudad Universitaria, Ave. Universidad # 3000, Ciudad…
ORCID-Profile: Martha Lucinda Contreras-Zentella, Rolando Hernández-Muñoz
Zitieren
APA
Contreras-Zentella, M. L., Hernández-Espinosa, L. C., & Hernández-Muñoz, R. (2025). Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption. Antioxidants, 14(12), 1494. https://doi.org/10.3390/antiox14121494
Vancouver
Contreras-Zentella ML, Hernández-Espinosa LC, Hernández-Muñoz R. Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption. Antioxidants. 2025;14(12):1494. doi:10.3390/antiox14121494
BibTeX
@article{ContrerasZentella2025,
author = {Contreras-Zentella, Martha Lucinda and Hernández-Espinosa, Lorena Carmina and Hernández-Muñoz, Rolando},
title = {Oxidative Stress in Liver Metabolic Dysfunction and Diseases, with a Focus on Hepatogenic Diabetes: Effect of Alcohol Consumption},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {12},
pages = {1494},
doi = {10.3390/antiox14121494}
}
EUVIMED